#GoldenCross $NBRV at 2.74 R12 HiLo 33% T1Y 10 buy fwdPE -3.3 DIV N/A #Nabriva Th #stocks #trading #finance #market

2019-04-13
43 Views

Golden Cross detected for NBRV (Nabriva Therapeutics) at the close price of 2.74. Trading at a 33 % level between the 52week High (6.05) and 52week Low (1.12). The average analyst 1-year target price is 10.0 with an average buy and a score of 0.0.

Golden Cross 12 % NBRV 2.74
Nabriva Therapeutics HiLo 32.9 %
Support 2.44 Resistance 3.07
50DMA 2.44 200DMA 2.43
52week high 6.05 52week low 1.12
10DMA 2.82 20DMA 2.82
100 Mean 2.13
Volume 701627 AvgDayVol 939141
MarketCap 190977168 EBITDA -81817000
Revenue 9656000 PE 0.00
P2S 19.78 P2B 0.00
Dividend 0.00 Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

#Levermann #ASIA  #BigCap #Buy WK16 $0688.HK (5)
Asia, Bull, Single UL Indicators
19 views
Asia, Bull, Single UL Indicators
19 views

#Levermann #ASIA #BigCap #Buy WK16 $0688.HK (5)

Andreas Aigner - 2019-04-22

TOP CAPs for #Levermann #ASIA #BigCap #Buy WK16 $0688.HK (5)

#Levermann #Global #MidCap #Sell WK15 $URI (-2), $WRK (-3), $TTWO (-2), $FFIV (2), $FDS (2), $LEA (4), $WLK (0), $AVY (1), $GPS (1), $AGNC (1)
Bear, Global Indicators, Single UL Indicators
25 views
Bear, Global Indicators, Single UL Indicators
25 views

#Levermann #Global #MidCap #Sell WK15 $URI (-2), $WRK (-3), $TTWO (-2), $FFIV (2), $FDS (2), $LEA (4), $WLK (0), $AVY (1), $GPS (1), $AGNC (1)

Andreas Aigner - 2019-04-21

TOP CAPs for #Levermann #Global #MidCap #Sell WK15 $URI (-2), $WRK (-3), $TTWO (-2), $FFIV (2), $FDS (2), $LEA (4),…

#Levermann #Global #MidCap #Buy WK15 $KEM (7)
Bull, Global Indicators, Single UL Indicators
23 views
Bull, Global Indicators, Single UL Indicators
23 views

#Levermann #Global #MidCap #Buy WK15 $KEM (7)

Andreas Aigner - 2019-04-21

TOP CAPs for #Levermann #Global #MidCap #Buy WK15 $KEM (7)

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.